Pharmacy Board of Australia v Tavakol

Link copied
Case Copied 29 min read
CITATION: Pharmacy Board of Australia v Tavakol [2014] QCAT 112
PARTIES: Pharmacy Board of Australia
(Applicant/Appellant)
v
Mr Jason Arash Tavakol
(Respondent)
APPLICATION NUMBER: OCR295-11
MATTER TYPE: Occupational regulation matters
HEARING DATE: 1 May 2013
HEARD AT: Brisbane
DECISION OF: Judge Alexander Horneman-Wren SC, Deputy President, assisted by:
Ms Karen Allen
Dr Karin Walduck
Ms Aileen Tan
DELIVERED ON: 8 May 2014
DELIVERED AT: Brisbane
ORDERS MADE:

1.     Jason Arash Tavakol’s registration is suspended for a period of one (1) month. The period of suspension is from 5 June 2014 to 3 July 2014 inclusive of those dates.

2.     The following conditions are imposed on the registrant’s registration following the period of suspension:

(a)   The registrant is to undergo a period of six (6) months supervised practice in an accredited pharmacy for not less than two (2) hours per month.

(b)   Upon completion of the period of supervision in condition (a), the registrant is to undergo a period of mentoring for not less than two (2) hours per month for six (6) months.

(c)   The mentoring must be face to face and focus on:

(i)    ethical decision making and dispensing, including strategies for the determination of therapeutic need and the supply of Schedule 2 and 3 drugs with particular reference to drugs know to be subject to abuse;

(ii)   strategies to resist pressure to dispense, whether the pressure is exerted by patient, prescribing doctors or employers; and

(iii)     the ability to communicate effectively with other health professionals regarding appropriate dispensing of prescriptions.

(d)   For the purpose of conditions (a) and (b), the registrant is to nominate a supervisor/mentor for the approval of the Board, who must be a practicing pharmacist and senior to the registrant in age and experience.

(e)   The mentor must provide a report in writing to the Board at the end of each quarter and at the completion of the mentoring period.

(f)    In addition to completing the mandatory continuing professional development (‘CPD’) requirements set out in the Board’s Registration Standard for CPD, the registrant is to complete an additional CPD module in the Domain 3 (Leadership and Management). The additional module is to be completed within twelve (12) months.

(g)   The registrant is to complete an accredited course on proper pharmacy management within eighteen (18) months.

(h)   The registrant is to complete an accredited course on appropriate dispensing within eighteen (18) months.

(i)    For each of conditions (g) and (h):

(i)    the registrant is to nominate a course for approval of the Board; and

(ii)   the registrant is to submit documentary evidence to the Board upon completion of the course.

(j)    The registrant is to retain membership of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia for two (2) years.

(k)   The registrant is to maintain the Quality Care Pharmacy Program accreditation, or equivalent accreditation, for the Pharmacy and any other pharmacy he owns for a period of three (3) years form the date of any Tribunal decision.

(l)    The registrant is to…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Pharmacy Board of Australia v Tavakol and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2014] QCAT 112
Decision Date

CaseChat Overview and Summary

The matter before the tribunal was a disciplinary proceeding brought by the Pharmacy Board of Australia against Jason Arash Tavakol, a registered pharmacist and owner of a pharmacy. The Board alleged that the respondent's conduct amounted to professional misconduct due to a significant increase in the volume of pseudoephedrine being ordered by the pharmacy, which the respondent ought to have known was being targeted by drug runners. The Board sought a suspension of the respondent's registration, with a period of actual suspension followed by a suspended suspension.

The primary legal issue before the tribunal was whether the respondent's conduct constituted professional misconduct warranting disciplinary action. A secondary issue was whether the tribunal had the authority to impose a suspended suspension on the respondent's registration under the Health Practitioner Regulation National Law (Queensland).

The tribunal found that the respondent's conduct did indeed amount to professional misconduct. The respondent had failed to exercise proper professional judgment and oversight, resulting in the pharmacy being used for illicit activities. The tribunal held that the respondent's actions demonstrated a lack of awareness and understanding of the ethical and legal responsibilities of a pharmacist. The tribunal also found that it had the authority to impose a suspended suspension on the respondent's registration, pursuant to section 116(3) of the Health Practitioner Regulation National Law (Queensland).

The tribunal ordered that the respondent's registration be suspended for a period of one month, from 5 June 2014 to 3 July 2014. Following the suspension, the respondent was to undergo a period of supervised practice and mentoring, complete additional continuing professional development modules, and take accredited courses on pharmacy management and appropriate dispensing. The respondent was also required to maintain membership in professional organisations and ensure that any pharmacies he owned met accreditation standards. The costs of these conditions were to be borne by the respondent. The review period for the conditions imposed on the respondent's registration was set at three years. Finally, the respondent was ordered to pay the costs of the Board's proceedings.

Orders

Orders of the court

1. Jason Arash Tavakol’s registration is suspended for a period of one (1) month. The period of suspension is from 5 June 2014 to 3 July 2014 inclusive of those dates.

2. The following conditions are imposed on the registrant’s registration following the period of suspension:

(a) The registrant is to undergo a period of six (6) months supervised practice in an accredited pharmacy for not less than two (2) hours per month.

(b) Upon completion of the period of supervision in condition (a), the registrant is to undergo a period of mentoring for not less than two (2) hours per month for six (6) months.

(c) The mentoring must be face to face and focus on:

(i) ethical decision making and dispensing, including strategies for the determination of therapeutic need and the supply of Schedule 2 and 3 drugs with particular reference to drugs know to be subject to abuse;

(ii) strategies to resist pressure to dispense, whether the pressure is exerted by patient, prescribing doctors or employers; and

(iii) the ability to communicate effectively with other health professionals regarding appropriate dispensing of prescriptions.

(d) For the purpose of conditions (a) and (b), the registrant is to nominate a supervisor/mentor for the approval of the Board, who must be a practicing pharmacist and senior to the registrant in age and experience.

(e) The mentor must provide a report in writing to the Board at the end of each quarter and at the completion of the mentoring period.

(f) In addition to completing the mandatory continuing professional development (‘CPD’) requirements set out in the Board’s Registration Standard for CPD, the registrant is to complete an additional CPD module in the Domain 3 (Leadership and Management). The additional module is to be completed within twelve (12) months.

(g) The registrant is to complete an accredited course on proper pharmacy management within eighteen (18) months.

(h) The registrant is to complete an accredited course on appropriate dispensing within eighteen (18) months.

(i) For each of conditions (g) and (h):

(i) the registrant is to nominate a course for approval of the Board; and

(ii) the registrant is to submit documentary evidence to the Board upon completion of the course.

(j) The registrant is to retain membership of the Pharmaceutical Society of Australia and the Pharmacy Guild of Australia for two (2) years.

(k) The registrant is to maintain the Quality Care Pharmacy Program accreditation, or equivalent accreditation, for the Pharmacy and any other pharmacy he owns for a period of three (3) years form the date of any Tribunal decision.

(l) The registrant is to be responsible for paying any costs associated with these conditions.

3. Pursuant to s 116(3) of the Health Practitioner Regulation National Law (Queensland), the review period for the conditions imposed on the registrant’s registration is three (3) years.

4. The registrant is to pay the costs of the Board of the proceedings as agreed or assessed by the Tribunal.

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established